Serologic Markers Do Not Predict Histologic Severity or Response to Treatment in Patients With Autoimmune Hepatitis

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 1, 2009, Pages 98-103

  Mehendiratta, Vaibhav ^a   Mitroo, Pradnya ^a   Bombonati, Alessandro ^a   Navarro, Victor J ^a   Rossi, Simona ^a   Rubin, Raphael ^a   Herrine, Steven K ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; SMOOTH MUSCLE ANTIBODY; TACROLIMUS;

ADULT; AGE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; GENDER; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PERCUTANEOUS BIOPSY; PREDICTION; RETROSPECTIVE STUDY; SCORING SYSTEM; SEROLOGY; TREATMENT RESPONSE;

ADULT; AGED; ANIMALS; AUTOANTIBODIES; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NECROSIS; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; TRANSAMINASES; TREATMENT OUTCOME;

EID: 58049219889     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.08.043     Document Type: Article

References (27)

1. Johnson P.J., and McFarlane I.G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 18 (1993) 998-1005
2. Alvarez F., Berg P.A., Bianchi F.B., et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
3. Czaja A.J., and Carpenter H.A. Validation of scoring system for the diagnosis of autoimmune hepatitis. Dig Dis Sci 41 (1996) 305-314
4. Carpenter H.A., and Czaja A.J. The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants. Clin Liver Dis 6 (2002) 685-705
5. Czaja A.J., and Norman G.L. Autoantibodies in the diagnosis and management of liver disease. J Clin Gastroenterol 37 (2003) 315-329
6. Czaja A.J., Carpenter H.A., Santrach P.J., et al. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 104 (1993) 1755-1761
7. Czaja A.J. The variant forms of autoimmune hepatitis. Ann Intern Med 125 (1996) 588-598
8. Czaja A.J. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 30 (1999) 394-401
9. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 354 (2006) 54-66
10. Feld J.J., Dinh H., Arenovich T., et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 42 (2005) 53-62
11. Vergani D., Alvarez F., Bianchi F.B., et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 41 (2004) 677-683
12. Tan E.M., Smolen J.S., McDougal J.S., et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities: II-potential for quantitation of antibody content. J Rheumatol 29 (2002) 68-74
13. Fritzler M.J., Wiik A., Tan E.M., et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities: III-comparative performance characteristics of academic and manufacturers' laboratories. J Rheumatol 30 (2003) 2374-2381
14. Fritzler M.J., Wiik A., Fritzler M.L., et al. The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res Ther 5 (2003) 192-201
15. Rondeel J.M., van Gelder W., van der Leeden H., et al. Different strategies in the laboratory diagnosis of autoimmune disease: immunofluorescence, enzyme-linked immunosorbent assay or both?. Ann Clin Biochem 36 (1999) 189-195
16. Bogdanos D.P., Invernizzi P., Mackay R., et al. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 14 (2008) 3374-3387
17. Goodman Z.D. Grading and staging for inflammation and fibrosis in chronic liver diseases. J Hepatol 47 (2007) 598-607
18. Knodell R.G., Ishak K.G., Black W.C., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1 (1981) 431-435
19. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
20. Johnson P.J., McFarlene I.G., McFarlene B.M., et al. Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for convenional auto-antibodies. J Gastroenterol Hepatol 5 (1990) 244-251
21. Czaja A.J., Hay J.E., and Rakela J. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc 65 (1990) 23-30
22. Czaja A.J., Carpenter H.A., Santrach P.J., et al. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 104 (1993) 1755-1761
23. Kaymakoglu S., Cakaloglu Y., Demir K., et al. Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis. J Hepatol 28 (1998) 78-83
24. Thiele D., DuCharme L., Cunningham M.R., et al. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients. Am J Gastroenterol 91 (1996) 300-308
25. Gassert D.J., Garcia H., Tanaka K., et al. Corticosteroid-responsive cryptogenic chronic hepatitis: evidence of seronegative autoimmune hepatitis. Dig Dis Sci 52 (2007) 2433-2437
26. Montano-Loza A.J., Carpenter H.A., and Czaja A.J. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage live disease. Hepatology 46 (2007) 1138-1145
27. Czaja A.J., and Freese D.K. Diagnosis and treatment of autoimmune hepatitis. Hepatology 36 (2002) 479-497